Effects of hypericum extract HYP 811 in patients with psychovegetative disorders.
The efficacy of tolerability of a 6-week course of Hypericum extract HYP 811 were investigated in a postmarketing surveillance study of 758 outpatients suffering from psychovegetative disorders. The investigations included a standardized list of typical somatic symptoms and global evaluations of the drug's efficacy and tolerability. By study end, 83.1% of patients had experienced a reduction in symptom severity, and the frequency of symptoms had improved by an average of 37.3%. After 3 weeks of treatment, the dosage could be reduced to one capsule per day in 35.8% of patients.
Mueller
B M
BM
Biocur Arzneimittel GmbH, Holzkirchen, Germany.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D008875:Middle Aged; D019370:Observation; D018458:Persistent Vegetative State; D010569:Perylene / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011794:Quercetin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014966:Xanthenes / Q000627:therapeutic use*
D000928:Antidepressive Agents; D014966:Xanthenes; D010569:Perylene; D011794:Quercetin